Paul Sargos: TMT and concomitant Chemo regimen for patients with Muscle Invasive Bladder Cancer / Camille Baudelin, cancer, Christophe Hennequin, Derek
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The CHMP has recommended repotrectinib for ROS1-positive non–small cell lung cancer and NTRK-positive solid tumors.
In 2014, the Molecular Tumor Board (MTB) was introduced into the literature by a publication in The Oncologist . Ten years later, MTBs have become…
Objective To evaluate the care of patients dying in hospital without support from specialists in palliative care (SPC), better understand their needs and factors influencing…
At the ESH 7th Translational Research Conference on Multiple Myeloma in 2024, the Multiple Myeloma Hub held a symposium on: How to sequence BCMA-directed therapies…
It is with pleasure that we invite you to the 9th BLADDR and 12th PROSCA edition of the Mirrors of Medicine Global Forum in GU Oncology, taking place in…
Colorectal Cancer provides a concise, readable overview of current and future management options in a fast-moving field, ideal for the busy clinician or healthcare professional.…
The CHMP has recommended the approval of pembrolizumab plus chemotherapy for first-line unresectable non-epithelioid malignant pleural mesothelioma.
Published online: September 14, 2024 Annals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides…
The CHMP has recommended the EU approval of isatuximab plus VRd for newly diagnosed, transplant-ineligible multiple myeloma.
